Showing posts with label Diagnostics. Show all posts
Showing posts with label Diagnostics. Show all posts

Monday, 11 September 2017

Global Blood Transfusion Diagnostics Market From 2017 - 2025: Automated Procedures Augur well for Future

Researchmoz added Most up-to-date research on "Global Blood Transfusion Diagnostics Market From 2017 - 2025: Automated Procedures Augur well for Future" to its huge collection of research reports.

This report provides in-depth region wise and country wise analysis of the blood transfusion diagnostics market. Stakeholders of this report include manufacturers of blood transfusion diagnostics, raw material suppliers, research institutes involve in the research of blood transfusion diagnostics and new players planning to enter the market.

The report provides qualitative and quantitative analysis of the global blood transfusion diagnostics market. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market information. Quantitative analysis includes major players with their reported revenue, market size, and forecast for the global blood transfusion diagnostics market in major countries globally such as the U.S., Canada, Germany, Italy, France, United Kingdom, Spain, Japan, China, Brazil, Mexico, South Africa and Saudi Arabia. Market revenue is provided in terms of US$ Mn from 2015 to 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 for all the segments, considering 2016 as the base year. The executive summary of the report provides a snapshot of the blood transfusion diagnostics with information on leading segments, country wise market information with respect to the market size, growth rate (CAGR %), and growth factors.

The market overview section comprises impact factors such as drivers, restraints, and opportunities for the global blood transfusion diagnostics market. These factors would aid the stakeholders in establishing a strong foothold in the global blood transfusion diagnostics market. Furthermore, the market overview section comprises key industry events, product overview, market attractiveness analysis and emerging trend in the blood transfusion diagnostics market. The market attractiveness analysis provides a graphical view comparing the growth and market dynamics in various segments and country wise to identify the most attractive market.

Global Blood Transfusion Diagnostics Market: Segmentation
The blood transfusion diagnostics market has been segmented as by product type, by application, by end-user and by geography. Based on product type, the market has been segmented into kits & reagents and instruments. Based on application, the market has been segmented into blood grouping and disease screening (molecular disease screening and serological disease screening). Based on end-user, the market has been segmented into hospitals, diagnostic laboratories, blood banks and others.
Geographically, the blood transfusion diagnostics market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, analysis for the major countries comprising U.S. Canada, Germany, Italy, France, U.K., Spain, Rest of Europe, Japan , China, India, Rest of APAC, Brazil, Mexico, Rest of LATAM, South Africa, Saudi Arabia, Rest of MEA have also been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the blood transfusion diagnostics market in various regions has been provided in this section.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1320915

This report also includes various ups and downs about particular country or geography that has impacted the overall market globally. The report provides a detailed outline/blueprint of the blood transfusion diagnostics market globally that will assist new companies in establishing their presence and market players in expanding their market share in the market.

Global Blood Transfusion Diagnostics Market: Competitive Landscape
The report concludes with the company profile section which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies and recent developments for market players. The major players that are profiled in the report include Abbott Laboratories, BAG Health Care GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Grifols, S.A., Hologic, Inc. , Immucor, Inc and others.

The global blood transfusion diagnostics market has been segmented into:

Global Blood Transfusion Diagnostics Market, by Product Type
  • Kits & Reagents
  • Instruments
     
Global Blood Transfusion Diagnostics Market, by Application
  • Blood Grouping
  • Disease Screening
  • Molecular Disease Screening
  • Serological Disease Screening
     
Global Blood Transfusion Diagnostics Market, by End-user
  • Hospitals
  • Diagnostic Laboratories
  • Blood Banks
  • Others
     
Global Blood Transfusion Diagnostics Market, by Geography
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • Italy
  • France
  • U.K.
  • Spain

Tuesday, 8 August 2017

Global Cancer Diagnostics Market Analysis By Type, By Imaging Tests & By Region: Trends, Opportunities and Forecasts 2016 - 2021

Researchmoz added Most up-to-date research on "Global Cancer Diagnostics Market Analysis By Type, By Imaging Tests & By Region: Trends, Opportunities and Forecasts 2016 - 2021" to its huge collection of research reports.

Rising incidences of cancer owing to unhealthy food habits and sedentary lifestyle coupled with the growing technological advancements has resulted in the growth of global cancer diagnostics market
Market for cancer diagnostics is growing at a steady pace due to higher incidences of cancer among the population, where emerging markets are expected to achieve higher growth.

Given the growing demand for early detection of cancer, tumor marker tests are gaining prominence and are projected to witness stronger growth in the coming years.

Growth in the incidences of cancer across the globe is due to the sedentary lifestyle such as increasing tobacco consumption and unhealthy eating habits.

Advancement in genomics has resulted in the growing cancer research, due to which early detection of cancer is gaining popularity.

Global Cancer Diagnostics Market is forecasted to grow at a CAGR of 8.8% during 2016 2021F, on account of rising incidences of cancer globally, along with the increasing technological advancement driven by focus on cancer research

North America region remains the major market followed by Europe in the actual period. In the forecast period, APAC region will witness strong growth driven by countries such as India and China.

According to Azoth Analytics research report, Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts (2016-2021), Global Cancer Diagnostics market is projected to exhibit a CAGR of over ~8.8% during 2016 - 2021. On the basis of market segment, Global Cancer Diagnostics Market has been segmented by type (By Type: Imaging Tests, Endoscopy, Biopsy and Tumor Marker, By Imaging Tests Sub-Type: MRI, Ultrasound, PET-CT Scan, Mammography, By Region: North America, Latin America, APAC, Europe and MEA.)

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=760225

Scope of the Report
The report provides Segmentation by Type
Imaging Tests
Endoscopy
Biopsy
Tumor Marker

The report provides Segmentation by Sub- Type
Imaging Tests : MRI, Ultrasound, PET-CT Scan, Mammography

The report provides coverage by Region

North America
Europe
Asia Pacific
Latin America
Middle East and Africa (MEA)

Table Of Content

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations
3.1. North America and Europe to drive the Cancer Diagnostic Market
3.2. Lung, Breast, Bowel and Prostrate Cancers to remain the major cause of Cancer Diagnostics
3.3. Cancer Imaging Test would form the largest market segment for Cancer Diagnosis

4. Global Cancer Diagnostics Market: An Overview
4.1. Product Overview
4.1.1.Global Cancer Diagnostics Market, By Value 2011-2015
4.1.2.Global Cancer Diagnostics Market, By Value 2016-2021F
Global Cancer Diagnostics Market: By Type (Imaging Tests, Endoscopy, Biopsy, Tumour Marker Tests)
4.1. Global Imaging Tests Market

Browse More Details @ http://www.researchmoz.us/global-cancer-diagnostics-market-trends-opportunities-and-forecasts-2016-2021by-type-imaging-tests-endoscopy-biopsy-tumor-marker-by-imaging-tests-sub-type-mri-ultrasound-pet-ct-scan-mammography-by-region-north-america-latin-america-apa-report.html

Wednesday, 26 July 2017

HIV/AIDS Diagnostics Market to be Worth US$5.74 Billion by 2025: Competition Moderate on Account of Few Products Approved for Commercial Use

Researchmoz added Most up-to-date research on "HIV/AIDS Diagnostics Market to be Worth US$5.74 Billion by 2025: Competition Moderate on Account of Few Products Approved for Commercial Use" to its huge collection of research reports.

This report provides forecast and analysis of the HIV/AIDS diagnostics market on the global and regional levels. It provides historical data of 2016 along with forecast from 2017 to 2025 in terms of revenue (US$ Mn). The report also includes macroeconomic indicators along with an outlook on HIV/AIDS diagnostics globally. It includes drivers and restraints of the HIV/AIDS diagnostics market and their impact on each region during the forecast period. The report also comprises of the study of current issues with end users and opportunities for HIV/AIDS diagnostics manufacturers in the global market.

In order to provide users with comprehensive view of the market, we have included detailed competitive analysis and market players with unique selling propositions. The competitive dashboard included in the report provides detailed comparison of HIV/AIDS diagnostics manufacturers on parameters such as product offerings, revenue, key strategies, and recent developments. The study encompasses market attractiveness analysis, by product type, by test type, by end users and region.

Global HIV/AIDS Diagnostics Market: Research Methodology
Market value for global HIV/AIDS diagnostics have been estimated based on utility of HIV/AIDS diagnostics for all product types. The revenue is forecasted through regional pricing trends. Market size and forecast for each segment have been provided in the context of global and regional markets. The HIV/AIDS diagnostic market has been analyzed based on expected demand. Most of the key end users have been considered and potential applications have been estimated on the basis of secondary sources and feedback from primary respondents. Regional demand patterns have been considered while estimating the market for various end users of HIV/AIDS diagnostics in different regions.
Bottom-up approach has been used to estimate the HIV/AIDS diagnostics market size, and top-down approach has been used to validate the market number. The market has been forecasted based on constant currency rates. A number of secondary sources consulted during the course of the study include Factiva, NCBI, Google books, company annual reports, websites, white papers, and publications.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1253917

Global HIV/AIDS Diagnostics Market: Segmentation
The report includes revenue generated from sales of HIV/AIDS diagnostics in all regions and important countries in the regions. By product type, the global HIV/AIDS diagnostics market has been segmented into kits and reagents, instruments and others. On the basis of test type the HIV/AIDS diagnostics market is segmented into rapid tests (POC), ELISA, nucleic acid tests and others. On the basis of end users, the global HIV/AIDS diagnostics market is segmented into hospitals, private diagnostics laboratories, academic and research institutes and others. Geographically, the market is segmented into regions viz. North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Global HIV/AIDS Diagnostics Market: Competitive Analysis
The report provides detailed competitive dashboard and company profiles of key participants operating in the global market. Some of the key players in the global HIV/AIDS diagnostics market include Alere, Hologic, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Abbott Laboratories, Siemens Healthineers, OraSure Technologies, Inc., Chembio Diagnostic Systems etc.

The global HIV/AIDS diagnostics market is segmented as follows:

Global HIV/AIDS Diagnostics Market – By Product Type
  • Kits and Reagents
  • Instruments
  • Others
Global HIV/AIDS Diagnostics Market – By Test Type
  • Rapid Tests (POC)
  • ELISA
  • Nucleic Acid Tests
  • Others
Global HIV/AIDS Diagnostics Market – By End Users
  • Hospitals
  • Private Diagnostics Laboratories
  • Academic and Research Institutes
  • Others
Global HIV/AIDS Diagnostics Market – By Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy

Monday, 24 July 2017

Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers

Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports.

This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
C.R. Bard, Inc.
GE Healthcare
Becton, Dickinson and Company
Abbott
Roche
Thermo Fisher Scientific
Agilent Technologies
Siemens Healthcare
Illumina

By types, the market can be split into
Diagnostic Reagent
Diagnostic Instrument

By Application, the market can be split into
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Other Cancers

By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1193717

Table of Contents

Global Cancer Diagnostics Market Professional Survey Report 2017

1 Industry Overview of Cancer Diagnostics
1.1 Definition and Specifications of Cancer Diagnostics
1.1.1 Definition of Cancer Diagnostics
1.1.2 Specifications of Cancer Diagnostics
1.2 Classification of Cancer Diagnostics
1.2.1 Diagnostic Reagent
1.2.2 Diagnostic Instrument
1.3 Applications of Cancer Diagnostics
1.3.1 Breast Cancer
1.3.2 Lung Cancer
1.3.3 Colorectal Cancer
1.3.4 Melanoma
1.3.5 Other Cancers
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

2 Manufacturing Cost Structure Analysis of Cancer Diagnostics

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Cancer Diagnostics
2.3 Manufacturing Process Analysis of Cancer Diagnostics
2.4 Industry Chain Structure of Cancer Diagnostics

Browse More Details @ http://www.researchmoz.us/global-cancer-diagnostics-market-professional-survey-report-2017-report.html

Wednesday, 5 July 2017

Next-Generation Sequencing Technologies Available For Global Cancer Diagnostics Device Market During The Forecast Period 2016 - 2020

Researchmoz added Most up-to-date research on "Next-Generation Sequencing Technologies Available For Global Cancer Diagnostics Device Market During The Forecast Period 2016 - 2020" to its huge collection of research reports.

An increase in any particular internal and external factor can lead to cancer. Currently, the demand for cancer therapy and research in complex molecular tumor diagnostics is high. Researchers are using automated solutions to isolate genetic materials from small tissue samples. The complex genetic analysis of samples using next-generation sequencing technologies helps researchers analyze the individual and relevant pattern of genetic changes in tumor tissues, helping in determining the most effective treatment options.

The development of sophisticated technologies such as microarray, next-generation sequencing, mass spectrometry, automated DNA sequencing, fluorescence in-situ hybridization, and comparative genomic hybridization has opened new avenues for cancer biomarkers. These technologies are capable of detecting abnormalities in the gene expression and the genetic structure of cancer cells. In addition, these technologies can analyze changes in the DNA, RNA, and chromosomes from tissue samples of a tumor.

Technavios analysts forecast the global cancer diagnostics devices market to grow at a CAGR of 18.07% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global cancer diagnostics devices market for 2016-2020 To calculate the market size, we consider revenue generated from the sales of molecular and companion cancer diagnostic devices.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Cancer Diagnostics Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Abbott Diagnostics
Agilent Technologies
BD
bioMrieux
Qiagen
Roche Diagnostics

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=741826

Other prominent vendors

Affymetrix
Ambry Genetics
Annoroad
Aviva Biosciences
Biochain
Bio-Rad
Cancer Genetics
Cepheid
CompanionDx
DiagnoCure
Epic Sciences
Epigenomics
Genomic Health
HalioDX
Hologic
Illumina
Myriad Genetics
Thermo Fisher Scientific
Ventana Medical Systems
Vysis

Market driver
Demand for personalized medicines
For a full, detailed list, view our report

Market challenge
High cost of developing companion diagnostics
For a full, detailed list, view our report

Market trend

Demand for personalized medicines
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=741826

Sunday, 11 June 2017

Production, Consumption, Revenue (Million USD), Market Share And Growth Rate Of Global Poultry Diagnostics Market, 2017

Researchmoz added Most up-to-date research on "Production, Consumption, Revenue (Million USD), Market Share And Growth Rate Of Global Poultry Diagnostics Market, 2017" to its huge collection of research reports.

In this report, the global Poultry Diagnostics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Poultry Diagnostics in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India

Global Poultry Diagnostics market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Idexx Laboratories
Zoetis
Thermo Fisher Scientific
Qiagen N.V.
GD Animal Health
IDVet
Affinitech
Agrobiotek Internacional
Biochek
Bionote
Boehringer Ingelheim
Bioingentech Biotechnologies
Megacor Diagnostik

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
ELISA
PCR

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1099496

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Poultry Diagnostics for each application, including
Avian Salmonellosis
Avian Influenza
Newcastle Disease
Avian Pasteurellosis
Encephalomyelitis
Infectious Bronchitis

Table of Contents

Global Poultry Diagnostics Market Research Report 2017

1 Poultry Diagnostics Market Overview
1.1 Product Overview and Scope of Poultry Diagnostics
1.2 Poultry Diagnostics Segment by Type (Product Category)
1.2.1 Global Poultry Diagnostics Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Poultry Diagnostics Production Market Share by Type (Product Category) in 2016
1.2.3 ELISA
1.2.4 PCR
1.3 Global Poultry Diagnostics Segment by Application
1.3.1 Poultry Diagnostics Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Avian Salmonellosis
1.3.3 Avian Influenza
1.3.4 Newcastle Disease
1.3.5 Avian Pasteurellosis
1.3.6 Encephalomyelitis
1.3.7 Infectious Bronchitis

2 Global Poultry Diagnostics Market Competition by Manufacturers
2.1 Global Poultry Diagnostics Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Poultry Diagnostics Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Poultry Diagnostics Production and Share by Manufacturers (2012-2017)
2.2 Global Poultry Diagnostics Revenue and Share by Manufacturers (2012-2017)
2.3 Global Poultry Diagnostics Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Poultry Diagnostics Manufacturing Base Distribution, Sales Area and Product Type
2.5 Poultry Diagnostics Market Competitive Situation and Trends

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1099496

Wednesday, 29 March 2017

ResearchMoz: Molecular Diagnostics Global Market For The Period 2017 - 2020

Researchmoz added Most up-to-date research on "ResearchMoz: Molecular Diagnostics Global Market For The Period 2017 - 2020" to its huge collection of research reports.

The traditional trial and error techniques that were used in the field of medicine are now being replaced by accurate, safe, marker-assisted, molecular-guided treatments. Molecular diagnostics is one such technique. This is a technique that involves measurement and analysis of DNA and RNA at the molecular level to detect changes in biochemical pathways. The aim of performing these tests is to determine the location of a disease and its activity. Wide scope of application, specificity, and quick turnaround time are factors that are contributing to its importance in the IVD market.

Technavios analysts forecast the global molecular diagnostics market to grow at a CAGR of 10.38% during the period 2016-2020.

Covered in this report 
The report covers the present scenario and the growth prospects of the global molecular diagnostics market for 2016-2020. To calculate the market size, revenue generated from the sales of equipment such as automated real-time PCR, mass spectroscopy, and DNA sequencing and DNA microarray diagnostic devices, consumables, and reagents is considered.

The market is divided into the following segments based on geography: 
Americas
APAC
EMEA

Technavio's report, Global Molecular Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Key vendors 
Abbott Laboratories
Hologic Inc.
Qiagen
Roche Diagnostics (a division of F. Hoffmann-La Roche Ltd.)
Siemens Healthcare GmbH 

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=711546

Other prominent vendors 
AsuraGen
Ahram Biosystem
Analytik Jena
BD
Bio-Rad
EKF Molecular Diagnostics
EMD Millipore
HTG Molecular
InBios International
Maxim Biomedical
Mindray
Myriad Genetics
Ortho Clinical Diagnostics
Ras Lifesciences
Trivitron Healthcare
ThermoFisher Scientific

Market driver 
Key to cost-effective diagnosis of cancer
For a full, detailed list, view our report 

Market challenge 
Reimbursement issues 
For a full, detailed list, view our report 

Market trend 
Growth of theranostics
For a full, detailed list, view our report 

Key questions answered in this report 
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors? 

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=711546

Monday, 20 February 2017

In-Vitro Diagnostics Packaging Global Market Steadily Grow At A CAGR Of Around 3% Between The Period Of 2017 - 2020

ResearchMoz presents this most up-to-date research on "In-Vitro Diagnostics Packaging Global Market Steadily Grow At A CAGR Of Around 3% Between The Period Of 2017 - 2020".

Technavios market research analyst predicts the global in-vitro diagnostics (IVD) packaging market to grow at a CAGR of around 3% between the period of 2016 and 2020. The prospects for growth in this market are driven by the recent increase in diagnostic services and a rise in the incidence and prevalence of chronic diseases and infections. Additionally, the growing practice of self-testing by patients at home is a noteworthy factor that incites market growth during the forecast period.

The significant market growth observed in emerging countries is the key driver for the growth of this market. In recent times, it has been observed that product manufacturers are focusing on emerging economies, such as Brazil, Russia, India, and China (BRIC), to expand their operations. The improvement of the existing healthcare infrastructure in these countries will result in the augmented demand for IVD packaging during the forecast period.

Product-type segmentation of the in-vitro diagnostics packaging market
Bottles and vials
Tubes
Petri dishes
Closures

In this market study, analysts have estimated the bottles and vials segment to be the highest revenue generating segment during the forecast period. The ability of vials and bottles to withstand high temperatures, chemical shocks, and thermal shocks will result in its augmented adoption during the predicted period.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=483949

Geographical segmentation of the in-vitro diagnostics packaging market
Americas
APAC
EMEA

Technavio market research analysts anticipate the Americas to be the largest market for IVD packaging during the forecast period. Rising aging population and an increase in the number of people with chronic and infectious diseases will bolster the demand for diagnostic products and services, which in turn will foster growth in this market during the estimated period.

Competitive landscape and key vendors
The vendors in this market compete in the complex and challenging medical devices industry, which is subject to frequent changes. To succeed in this market, the vendors need to invest in patent protection as it will help them to augment their revenue generating capacity. Furthermore, to establish themselves in this market, the vendors have to focus on improving their distribution networks rather than marketing their products.

The leading vendors in the market are
Bio-Rad
Corning
Greiner Bio-One
Narang Medical

Other prominent vendors in the market include Baidefu, Bellco Glass Crystalgen, Duran Group, Eppendorf, Kimble Chase Life Science, Sarstedt, VITLAB.

Key questions answered in the report include
What will the market size and the growth rate be in 2020
What are the key factors driving the global in-vitro diagnostics packaging market
What are the key market trends impacting the growth of the in-vitro diagnostics packaging
What are the challenges to market growth
Who are the key vendors in this market space
What are the market opportunities and threats faced by the vendors in the global in-vitro diagnostics packaging market
Trending factors influencing the market shares of the Americas, APAC, and EMEA.
What are the key outcomes of the five forces analysis of the in-vitro diagnostics packaging market
Technavio also offers customization on reports based on specific client requirement.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=483949

Tuesday, 31 January 2017

Current Trends In Global Hemostasis Market During The Period 2017 - 2019

Researchmoz added Most up-to-date research on "Current Trends In Global Hemostasis Market During The Period 2017 - 2019" to its huge collection of research reports.

Hemostasis is the procedure of interaction between blood vessels, platelets and coagulation protein to stop bleeding. Sometimes, bleeding disorder occurs due to vascular and coagulation abnormalities. These abnormalities could be inherited or acquired. Acquired disorders are the most common by far, majorly thrombocytopenia and other abnormalities include trauma, anticoagulant rodenticide, vitamin K deficiency, disseminated intravascular coagulation (DIC), Von Willebrand disease (vWD), deficiency of intrinsic and extrinsic factors, dysfibrinogenemia, Monoclonal Gammopathy and congenital platelet function defect. The hemostasis market is segmented into three major categories based on the types of products, as topical hemostats, infusible hemostats and advanced hemostats and sealants. Topical hemostats are further fragmented into three main segments which include:
  • Collagen
  • Oxidized regenerated cellulose (ORC)
  • Gelatin

Topical hemostats are mostly used in surgery settings for hemostatis. Collagen among these is majorly used as it acts immediately and starts blood clotting by natural pathway. Topical agents are preferred over other agents due to their ease of use, efficiency, biodegradable nature and cost effectiveness. The other major method to treat hemostasis disorder is by using infusible hemostats. The major products which consist of infusible hemostats include:

  • Platelet concentrates from donor blood
  • FVIII derived from blood
  • Fresh frozen plasma
  • Prothrombin complex

This method of treatment is used very rarely to treat hemostasis disorder and is used only under some specific conditions. For instance, fresh frozen plasma and prothrombin complex is majorly used to treat severe hemorrhages. Advanced hemostats and sealants market consists of products which have came into existence in recent years and is considered as the best treatment option. Some of the products of this market are still under research pipeline. Advanced hemostats and sealants segment of the hemostasis market includes following categories:

  • Flowable
  • Thrombin
  • Fibrin
  • Synthetic sealants

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=206939

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

  • North America
  • Asia Pacific
  • Europe
  • Rest of the World 

This report provides comprehensive analysis of 

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years

Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future

Sunday, 1 January 2017

Strategies Of Healthcare For Global Hepatitis B and C Diagnostics Market 2017-2020

ResearchMoz presents this most up-to-date research on "Strategies Of Healthcare For Global Hepatitis B and C Diagnostics Market 2017-2020".

Hepatitis B diagnostic tests include HBV serologic tests, molecular deoxyribonucleic acid (DNA) tests, histology tests, and laboratory tests. HBV serologic tests involve the measurement of antigens and antibodies. Hepatitis C diagnostic tests include anti-HCV serologic test, HCV recombinant immunoblot assay (RIBA) antibody test, and HCV molecular ribonucleic acid (RNA) testing. Anti-HCV is the serologic test used for screening.

Technavios analysts forecast the global hepatitis B and C diagnostics market to grow at a CAGR of 6.35% during the period 2016-2020.

Covered in this report 
The report covers the present scenario and the growth prospects of the global hepatitis B and C diagnostics market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of immunodiagnostics and nucleic acid test (NAT) instruments and consumables to hospitals, diagnostic centers, and research institutes.

The market is divided into the following segments based on geography: 
Americas
APAC
EMEA

Technavio's report, Global Hepatitis B and C Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Key vendors 
Abbott Diagnostics
Roche Diagnostics
Siemens Healthcare
QIAGEN

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=810437

Other prominent vendors 
Affymetrix
Allele Biotechnology
Axis-Shield
Becton Dickinson
bioMrieux
Cepheid
Chembio Diagnostics
DiaMetra
DiaSorin
Enzo Life Sciences
Hologic
ImmunoDX
MedMira
OraSure Technologies
Quest Diagnostics
Quidel
Randox Laboratories
Vela Diagnostics
Vital Diagnostics
ZEUS Scientific

Market driver 
Strategies of healthcare organizations toward simplifying the diagnostic process
For a full, detailed list, view our report 

Market challenge 
Regulatory and reimbursement hurdles limit the adoption rate
For a full, detailed list, view our report 

Market trend 
Advent of immunosensors in the HBV and HCV diagnostic tests
For a full, detailed list, view our report 

Key questions answered in this report 
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors? 

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=810437